Immuno-PET imaging of 89Zr labeled anti-PD-L1domain antibody

被引：0

作者：

Li, Dan ^{[1
]}

Cheng, Siyuan ^{[1
]}

Zhu, Xiao-Hua ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Nucl Med & PET, Wuhan, Hubei, Peoples R China

来源：

JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷

关键词：

PD-L1; domain antibody; Zr-89; immuno-PET imaging;

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

1135

引用

页数：2

共 50 条

[41] A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
Puyalto, Ander
Rodriguez-Remirez, Maria
Lopez, Ines
Iribarren, Fabiola
Simon, Jon Ander
Ecay, Marga
Collantes, Maria
Vilalta-Lacarra, Anna
Francisco-Cruz, Alejandro
Solorzano, Jose Luis
Sandiego, Sergio
Penuelas, Ivan
Calvo, Alfonso
Ajona, Daniel
Gil-Bazo, Ignacio
FRONTIERS IN IMMUNOLOGY, 2023, 14
[42] 89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
Jung, Kyung-Ho
Park, Jin Won
Lee, Jin Hee
Moon, Seung Hwan
Cho, Young Seok
Lee, Kyung-Han
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (05) : 656 - 664
[43] Development of a 89Zr radiolabeled anti-CD33 antibody for PET imaging of Acute Myeloid Leukemia
Buckway, Brandon
Burrell, Lance
Shami, Paul
Kosak, Ken
Lum, David
Yap, Jeffrey
JOURNAL OF NUCLEAR MEDICINE, 2020, 61
[44] Preclinical development of a 89Zr-labeled human antibody as a novel immuno-PET agent for noninvasive cancer detection and monitoring response to treatment
Singh, Abhay Kumar
Lewis, Calvin D.
Boas, Cristian Awv
Diebolder, Philipp
Jethva, Prashant N.
Rhee, Aaron
Song, Jong Hee
Goo, Young Ah
Li, Shunqiang
Liu, Yongjian
Rogers, Buck
Kapoor, Vaishali
Hallahan, Dennis E.
CANCER RESEARCH, 2023, 83 (07)
[45] 89Zr-labeled anti-PD-L1 CX-072 PET imaging in human xenograft and syngeneic tumors
Giesen, D.
Broer, L. N.
Lub-De Hooge, M. N.
Popova, I.
Howng, B.
Vasiljeva, O.
de Vries, E. G. E.
Pool, M.
ANNALS OF ONCOLOGY, 2019, 30
[46] Immuno-PET imaging with 89Zr-atezolizumab in low and high PD-L1 expressing renal cell carcinoma patient-derived xenograft models
Hao, Guiyang
Mulgaonkar, Aditi
Woolford, Layton
Nham, Kien
Guan, Bing
Brugarolas, James
Sun, Xiankai
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S236 - S237
[47] First-in-human PET imaging with the PD-L1 antibody 89Zr-atezolizumab
Bensch, Frederike
van der Veen, Elly
Jorritsma, Annelies
Lub-de Hooge, Marjolijn
Boellaard, Ronald
Oosting, Sjoukje
Schroder, Carolien
Hiltermann, Jeroen
van der Wekken, Anthonie
Groen, Harry
Fine, Bernard
McKnight, Nathan
Bohorquez, Sandra Sanabria
Williams, Simon
Veronese, Luisa
Mancao, Christoph
Brouwers, Adrienne H.
de Vries, Elisabeth
CANCER RESEARCH, 2017, 77
[48] Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
Bridoux, Jessica
Broos, Katrijn
Lecocq, Quentin
Debie, Pieterjan
Martin, Charlotte
Ballet, Steven
Raes, Geert
Neyt, Sara
Vanhove, Christian
Breckpot, Karine
Devoogdt, Nick
Caveliers, Vicky
Keyaerts, Marleen
Xavier, Catarina
BIOMOLECULES, 2020, 10 (10) : 1 - 15
[49] 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar
Joseph A. O’Donoghue
Volkan Beylergil
Serge Lyashchenko
Shutian Ruan
Stephen B. Solomon
Jeremy C. Durack
Jorge A. Carrasquillo
Robert A. Lefkowitz
Mithat Gonen
Jason S. Lewis
Jason P. Holland
Sarah M. Cheal
Victor E. Reuter
Joseph R. Osborne
Massimo F. Loda
Peter M. Smith-Jones
Wolfgang A. Weber
Neil H. Bander
Howard I. Scher
Michael J. Morris
Steven M. Larson
European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 2093 - 2105
[50] Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model
Freddy E. Escorcia
Jeffrey M. Steckler
Dalya Abdel-Atti
Eric W. Price
Sean D. Carlin
Wolfgang W. Scholz
Jason S. Lewis
Jacob L. Houghton
Molecular Imaging and Biology, 2018, 20 : 808 - 815

← 1 2 3 4 5 →